| David B Strider, PHARMD | |
|
909 E Wishkah St, Aberdeen, WA 98520-2901 | |
| (360) 532-7875 | |
| (360) 538-9880 |
| Full Name | David B Strider |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 909 E Wishkah St, Aberdeen, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982012985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH00060168 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David B Strider, PHARMD 909 E Wishkah St, Aberdeen, WA 98520-2901 Ph: (360) 532-7875 | David B Strider, PHARMD 909 E Wishkah St, Aberdeen, WA 98520-2901 Ph: (360) 532-7875 |
News Archive
Results presented today at The International Liver Congress 2015 show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 mono-infected patients. These results are significant because whilst other combinations have been widely reported on, there have been few data until now regarding the use of SOF/DCV combination in real world situations.
Researchers from The Children's Hospital of Philadelphia, the University of Pennsylvania and the University of Iowa studied 653 adults, ranging in age from 20 to 32. The subjects, all of whom were white, had been measured as newborns while participating in infant formula studies in Iowa. Those who had gained weight more rapidly during their first week were significantly more likely to be overweight decades later.
Every year nearly 6.2 million bone fractures occur in the United States as a result of trauma and disease. Current standards for bone repair can lead to rapid bone fusion but with limited mechanical strength often due to the lack of cortical bone tissue which is difficult to harvest without pain and severe morbidity. Funded by the National Science Foundation, Dr. Hongjun Wang, a professor in the Department of Chemistry, Chemical Biology and Biomedical Engineering at Stevens Institute of Technology and his collaborators have developed a revolutionary "bottom-up" approach for reconstructing intricate bone tissue with the potential to form hierarchical cortical bone.
CANCER RESEARCH UK and Cancer Research Technology - the charity's development and commercialisation arm - have reached a collaboration agreement with immatics Biotechnologies to trial their new treatment vaccine, IMA950, for glioblastoma multiforme (GMB), one of the most common forms of brain cancer.
› Verified 9 days ago
Dr. Michael Lee Henderson Jr., PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 221 W Heron St, Aberdeen, WA 98520 Phone: 360-532-8743 Fax: 360-538-0063 | |
Dr. Robert E Boyle Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 E Wishkah St, Aberdeen, WA 98520 Phone: 360-532-7875 Fax: 360-538-9880 | |
Kayla Mielke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 221 W Heron St, Aberdeen, WA 98520 Phone: 360-532-8743 | |
Kari Marie Pederson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 E Wishkah St, Aberdeen, WA 98520 Phone: 360-532-7875 | |
Dr. Tin Hoang Tran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 E Wishkah St, Aberdeen, WA 98520 Phone: 360-532-7875 Fax: 360-538-9880 | |
Mr. Frank William Bushell Jr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 221 W Heron St, Aberdeen, WA 98520 Phone: 843-437-7495 | |
Jessica Barrie, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 E Wishkah St, Aberdeen, WA 98520 Phone: 360-533-6320 |